Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

Understanding the Determinants of Decision Readiness in Kidney Replacement Therapy: Shared Decision Making, Health Literacy, and Population-Health Strategies

Kalantar-Zadeh K, Zisman-Ilani Y. Understanding the Determinants of Decision Readiness in Kidney Replacement Therapy: Shared Decision Making, Health Literacy, and Population-Health Strategies. Clin J Am[...]

Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009-2024

Adeyemo S, Crews DC, Lentine KL, Zisman-Ilani Y, Lincoln K, Flores GM, Bunnapradist S, Ferrey AJ, Reddy UG, Muzaale AD, Rule AD, Saunders M, Garg[...]

Reza Abdi, MD Appointed Director of Transplant Nephrology and Kidney Transplant Immunobiology, UCLA Kidney Transplant Immunobiology Program

The UCLA Department of Medicine is pleased to announce the establishment of the Kidney Transplant Immunobiology Program (KTIP) in the David Geffen School of Medicine[...]